ترێنجسترۆن

ترێنجسترۆن، لەژێر ناوی بازرگانی (ریتێـرۆید Reteroid ، ڕیترۆید Retroid) و (ڕیترۆن Retrone) دەرمانێکی پرۆجستینە کە پێشووتر بۆ چارەسەری حاڵەتەکانی سووڕی مانگانە بەکاردەھات بەڵام چیتر ناخرێتە ماڕکێتەکانەوە^[١]^[٢]^[٣]^[٤]^[٥] لە ڕێگەی دەمەوە بەکاردێت^[٦]

کاریگەرییە لاوەکییەکانی بریتییە لە سەرئێشە، بێ تاقەتی، ئازاری مەمک لە نێوان ئەوانی تر^[٤] ترینجیسترۆن لە ساڵی ١٩٧٤ وەک دەرمان ناسێنرا^[٢] و چیتر بەردەست نییە^[٥]

سەرچاوەکان[دەستکاری]

^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 259–. ISBN 978-1-4757-2085-3.
^ ^ئ ^ا Pascale Brudon (1983). Médicaments pour tous en l'an 2000?: les multinationales pharmaceutiques suisses face au tiers monde: l'exemple du Mexique. Editions d'en bas. pp. 93–. ISBN 978-2-8290-0039-3.
^ Dr. Ian Morton; I.K. Morton; Judith M. Hall (31 October 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 279–. ISBN 978-0-7514-0499-9.
^ ^ئ ^ا J. Horsky; J. Presl (6 December 2012). Ovarian Function and its Disorders: Diagnosis and Therapy. Springer Science & Business Media. pp. 329–. ISBN 978-94-009-8195-9.
^ ^ئ ^ا http://www.micromedexsolutions.com
^ Popper, T.L.; Watnick, A.S. (1971). Chapter 17. Steroids and Biologically Related Compounds. Annual Reports in Medicinal Chemistry. Vol. 6. pp. 162–181. doi:10.1016/S0065-7743(08)60972-0. ISBN 978-0-12-040506-0. ISSN 0065-7743. Ro 4-8347 (21), a potent orally active progestagen, when given at the dose of 4 mg/day in the second half of the cycle, was found clinically useful in anovulatory women with decreased ovarian function.109

دەروازەی زانست

[Elks2014-1] J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 259–. ISBN 978-1-4757-2085-3.

[Brudon1983-2] ئ ^ا Pascale Brudon (1983). Médicaments pour tous en l'an 2000?: les multinationales pharmaceutiques suisses face au tiers monde: l'exemple du Mexique. Editions d'en bas. pp. 93–. ISBN 978-2-8290-0039-3.

[MortonHall1999-3] Dr. Ian Morton; I.K. Morton; Judith M. Hall (31 October 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 279–. ISBN 978-0-7514-0499-9.

[HorskyPresl2012-4] ئ ^ا J. Horsky; J. Presl (6 December 2012). Ovarian Function and its Disorders: Diagnosis and Therapy. Springer Science & Business Media. pp. 329–. ISBN 978-94-009-8195-9.

[Micromedex-5] ئ ^ا http://www.micromedexsolutions.com

[PopperWatnick1971-6] Popper, T.L.; Watnick, A.S. (1971). Chapter 17. Steroids and Biologically Related Compounds. Annual Reports in Medicinal Chemistry. Vol. 6. pp. 162–181. doi:10.1016/S0065-7743(08)60972-0. ISBN 978-0-12-040506-0. ISSN 0065-7743. Ro 4-8347 (21), a potent orally active progestagen, when given at the dose of 4 mg/day in the second half of the cycle, was found clinically useful in anovulatory women with decreased ovarian function.109

[١]

[٢]

[٣]

[٤]

[٥]

[٦]